Analysis of serial tumor biopsies prior to and following 2 weeks of ENMD-2076 (n = 8 patients) demonstrated a treatment-induced decrease in cellular proliferation (Ki-67) (Fig. 3a) and MVD (CD34) (Fig. 3b) as assessed by IHC. This evidence concerns the gene MKI67 and neoplasm.